Empirical Antibiotic Treatment for Urosepsis

First-Line Options

• The European Association of Urology recommends piperacillin/tazobactam 2.5-4.5 g IV every 8 hours as a first-line empirical IV regimen for severe urinary tract infections progressing to sepsis 1, 2, 3
• The European Association of Urology suggests ceftriaxone 1-2 g IV daily as a first-line empirical IV regimen for severe urinary tract infections progressing to sepsis, with a higher 2 g dose recommended for sepsis 1, 2, 3
• The European Association of Urology recommends cefepime 2 g IV every 12 hours for severe infections 1, 2
• The European Association of Urology suggests ciprofloxacin 400 mg IV every 12 hours as a first-line empirical IV regimen for severe urinary tract infections progressing to sepsis 1, 2, 3
• The European Association of Urology recommends levofloxacin 750 mg IV daily as a first-line empirical IV regimen for severe urinary tract infections progressing to sepsis 1, 2, 3

Combination Therapy

• The European Association of Urology recommends adding aminoglycosides to cephalosporins for initial empirical therapy in septic patients, then de-escalating to monotherapy after 48-72 hours based on culture results 1, 2, 4
• Gentamicin 5 mg/kg IV daily is recommended, with once-daily dosing optimizing peak concentrations and reducing nephrotoxicity 1, 2, 4

Reserved Agents for Multidrug-Resistant Organisms

• The European Association of Urology recommends reserving carbapenems and novel beta-lactam/beta-lactamase inhibitor combinations for patients with early culture results indicating multidrug-resistant organisms or known colonization with ESBL-producing bacteria 1, 2, 3
• Meropenem 1 g IV every 8 hours is recommended for patients with multidrug-resistant organisms 1, 2, 5
• Imipenem/cilastatin 0.5 g IV every 8 hours is recommended for patients with multidrug-resistant organisms 1, 2
• Ceftazidime/avibactam 2.5 g IV every 8 hours is recommended for patients with multidrug-resistant organisms 1, 2, 5
• Ceftolozane/tazobactam 1.5 g IV every 8 hours is recommended for patients with multidrug-resistant organisms 1, 2
• Meropenem-vaborbactam 2 g IV every 8 hours is recommended for patients with multidrug-resistant organisms 1, 2, 5
• Plazomicin 15 mg/kg IV daily is recommended for patients with multidrug-resistant organisms 1, 2, 5

Critical Management Principles

• The European Association of Urology recommends initiating antimicrobial therapy within the first hour after diagnosis of urosepsis 6
• Obtaining two sets of blood cultures and urine culture is recommended before administering antibiotics 6
• Performing urgent imaging to identify obstruction or abscess is recommended before administering antibiotics 6
• Relieving any urinary tract obstruction immediately is critical for survival 6
• Administering cefepime IV over 30 minutes to achieve optimal time above MIC is recommended 4
• Once-daily dosing of gentamicin 5-7 mg/kg optimizes peak concentrations while reducing nephrotoxicity 4

Common Pitfalls to Avoid

• The European Association of Urology recommends avoiding fluoroquinolones empirically if local resistance exceeds 10% 1, 3
• The European Association of Urology recommends avoiding nitrofurantoin, oral fosfomycin, or pivmecillinam for pyelonephritis or urosepsis due to insufficient data supporting their efficacy in severe upper tract infections 1, 3
• Delaying source control is not recommended, and imaging should be performed immediately if clinical deterioration occurs, or within 72 hours if fever persists despite appropriate antibiotics 1, 2, 3

De-escalation Strategy

• The European Association of Urology recommends narrowing antibiotic therapy to the most specific effective agent within 48-72 hours based on culture and susceptibility results 1, 2, 3

Renal Dose Adjustments

• Adjusting cefepime dosing for patients with creatinine clearance ≤60 mL/min is recommended, with reduced doses for CrCL 30-60 mL/min and CrCL 11-29 mL/min 4

Antibiotic Selection for Urosepsis

Introduction to Antibiotic Regimens

• The Surviving Sepsis Campaign and European Association of Urology recommend administering antibiotics within the first hour after diagnosis, with a combination of ceftriaxone or cefepime and gentamicin, and de-escalating to monotherapy after 48-72 hours based on culture results, for patients with urosepsis 7

De-escalation and Treatment Duration

• The Surviving Sepsis Campaign strongly recommends daily assessment for de-escalation, narrowing to the most specific effective agent within 48-72 hours based on culture and susceptibility, and discontinuing combination therapy once clinical improvement occurs, with a treatment duration of 7-10 days being adequate for most cases with effective source control 7
• The Surviving Sepsis Campaign also recommends shorter courses (5-7 days) for patients with rapid clinical resolution after source control of urinary sepsis 7

Antibiotic Treatment for Urosepsis

First-Line Empirical Regimens

• The European Association of Urology recommends amoxicillin plus an aminoglycoside as a preferred combination therapy for initial antibiotic selection in urosepsis 8, 9
• The European Association of Urology also recommends second-generation cephalosporin plus an aminoglycoside as a preferred combination therapy for initial antibiotic selection in urosepsis 8, 9
• The European Association of Urology suggests ceftriaxone 1-2 g IV daily, use 2 g for sepsis, plus gentamicin 5 mg/kg IV daily as a combination therapy option 8
• Ciprofloxacin 400 mg IV every 12 hours OR levofloxacin 750 mg IV daily can be used ONLY if local resistance rate is <10%, patient has not used fluoroquinolones in the last 6 months, and patient is not from a urology department 8, 9

Reserved Agents for Multidrug-Resistant Organisms

• Meropenem 1 g IV every 8 hours can be reserved for patients with known ESBL-producing bacteria, carbapenem-resistant organisms, or early culture results indicating multidrug resistance 10
• Fourth-generation cephalosporins (cefepime) can be used if ESBL is absent 10
• Carbapenems are effective against multidrug-resistant Enterobacter infections, which are common in urosepsis 10

De-escalation Strategy

• Narrow antibiotic therapy to the most specific effective agent within 48-72 hours based on culture and susceptibility results to reduce resistance development without increasing mortality 10, 11

Treatment Duration

• 7-14 days is generally recommended for treatment duration, with 14 days recommended for men when prostatitis cannot be excluded 8, 9
• 7-day duration can be considered when patient is hemodynamically stable and afebrile for at least 48 hours 8, 9

Renal Dose Adjustments

• Adjust antibiotic dosing in patients with end-organ dysfunction, including renal and liver impairment, which affects antibiotic clearance 10, 11

Anaerobic Coverage

• Add metronidazole as the preferred anti-anaerobic agent in combination regimens when intra-abdominal involvement is suspected 10

Common Pitfalls to Avoid

• Do NOT use first or second-generation cephalosporins alone due to lack of efficacy against Enterobacter infections 10
• Do NOT use third-generation cephalosporins alone without aminoglycosides due to resistance concerns, particularly for Enterobacter species 10
• Do NOT routinely use antifungals unless patient has specific risk factors (recent abdominal surgery, anastomotic leak, necrotizing pancreatitis, ICU stay in previous 90 days) 10, 11